AAAAAA

   
Results: 1-19 |
Results: 19

Authors: COULTER SN SCHWAN WR NG EYW LANGHORNE MH RITCHIE HD WESTBROCKWADMAN S HUFNAGLE WO FOLGER KR BAYER AS STOVER CK
Citation: Sn. Coulter et al., STAPHYLOCOCCUS-AUREUS GENETIC-LOCI IMPACTING GROWTH AND SURVIVAL IN MULTIPLE INFECTION ENVIRONMENTS, Molecular microbiology, 30(2), 1998, pp. 393-404

Authors: SCHWAN WR COULTER SN NG EYW LANGHORNE MH RITCHIE HD BRODY LL WESTBROCKWADMAN S BAYER AS FOLGER KR STOVER CK
Citation: Wr. Schwan et al., IDENTIFICATION AND CHARACTERIZATION OF THE PUTP PROLINE PERMEASE THATCONTRIBUTES TO IN-VIVO SURVIVAL OF STAPHYLOCOCCUS-AUREUS IN ANIMAL-MODELS, Infection and immunity, 66(2), 1998, pp. 567-572

Authors: SHAWAR RM HUMBLE DJ VANDALFSEN JM STOVER CK HICKEY MJ STEELE S MITSCHER LA BAKER W
Citation: Rm. Shawar et al., RAPID SCREENING OF NATURAL-PRODUCTS FOR ANTIMYCOBACTERIAL ACTIVITY BYUSING LUCIFERASE-EXPRESSING STRAINS OF MYCOBACTERIUM-BOVIS BCG AND MYCOBACTERIUM-INTRACELLULARE, Antimicrobial agents and chemotherapy, 41(3), 1997, pp. 570-574

Authors: ARAIN TM RESCONI AE HICKEY MJ STOVER CK
Citation: Tm. Arain et al., BIOLUMINESCENCE SCREENING IN-VITRO (BIO-SIV) ASSAYS FOR HIGH-VOLUME ANTIMYCOBACTERIAL DRUG DISCOVERY, Antimicrobial agents and chemotherapy, 40(6), 1996, pp. 1536-1541

Authors: ARAIN TM RESCONI AE SINGH DC STOVER CK
Citation: Tm. Arain et al., REPORTER GENE TECHNOLOGY TO ASSESS ACTIVITY OF ANTIMYCOBACTERIAL AGENTS IN MACROPHAGES, Antimicrobial agents and chemotherapy, 40(6), 1996, pp. 1542-1544

Authors: HICKEY MJ ARAIN TM SHAWAR RM HUMBLE DJ LANGHORNE MH MORGENROTH JN STOVER CK
Citation: Mj. Hickey et al., LUCIFERASE IN-VIVO EXPRESSION TECHNOLOGY - USE OF RECOMBINANT MYCOBACTERIAL REPORTER STRAINS TO EVALUATE ANTIMYCOBACTERIAL ACTIVITY IN MICE, Antimicrobial agents and chemotherapy, 40(2), 1996, pp. 400-407

Authors: MOGHAZEH SL PAN X ARAIN T STOVER CK MUSSER JM KREISWIRTH BN
Citation: Sl. Moghazeh et al., COMPARATIVE ANTIMYCOBACTERIAL ACTIVITIES OF RIFAMPIN, RIFAPENTINE, AND KRM-1648 AGAINST A COLLECTION OF RIFAMPIN-RESISTANT MYCOBACTERIUM-TUBERCULOSIS ISOLATES WITH KNOWN RPOB MUTATIONS, Antimicrobial agents and chemotherapy, 40(11), 1996, pp. 2655-2657

Authors: MDLULI K SHERMAN DR HICKEY MJ KREISWIRTH BN MORRIS S STOVER CK BARRY CE
Citation: K. Mdluli et al., BIOCHEMICAL AND GENETIC DATA SUGGEST THAT INHA IS NOT THE PRIMARY TARGET FOR ACTIVATED ISONIAZID IN MYCOBACTERIUM-TUBERCULOSIS, The Journal of infectious diseases, 174(5), 1996, pp. 1085-1090

Authors: MAHAIRAS GG SABO PJ HICKEY MJ SINGH DC STOVER CK
Citation: Gg. Mahairas et al., MOLECULAR ANALYSIS OF GENETIC-DIFFERENCES BETWEEN MYCOBACTERIUM-BOVISBCG AND VIRULENT M-BOVIS, Journal of bacteriology, 178(5), 1996, pp. 1274-1282

Authors: CIRILLO JD STOVER CK BLOOM BR JACOBS WR BARLETTA RG
Citation: Jd. Cirillo et al., BACTERIAL VACCINE VECTORS AND BACILLUS-CALMETTE-GUERIN, Clinical infectious diseases, 20(4), 1995, pp. 1001-1009

Authors: WARD GA STOVER CK MOSS B FUERST TR
Citation: Ga. Ward et al., STRINGENT CHEMICAL AND THERMAL REGULATION OF RECOMBINANT GENE-EXPRESSION BY VACCINIA VIRUS VECTORS IN MAMMALIAN-CELLS, Proceedings of the National Academy of Sciences of the United Statesof America, 92(15), 1995, pp. 6773-6777

Authors: SHERMAN DR SABO PJ HICKEY MJ ARAIN TM MAHAIRAS GG YUAN Y BARRY CE STOVER CK
Citation: Dr. Sherman et al., DISPARATE RESPONSES TO OXIDATIVE STRESS IN SAPROPHYTIC AND PATHOGENICMYCOBACTERIA, Proceedings of the National Academy of Sciences of the United Statesof America, 92(14), 1995, pp. 6625-6629

Authors: STOVER CK
Citation: Ck. Stover, RECOMBINANT VACCINE DELIVERY SYSTEMS AND ENCODED VACCINES, Current opinion in immunology, 6(4), 1994, pp. 568-571

Authors: LANGERMANN S PALASZYNSKI S SADZIENE A STOVER CK KOENIG S
Citation: S. Langermann et al., SYSTEMIC AND MUCOSAL IMMUNITY INDUCED BY BCG VECTOR EXPRESSING OUTER-SURFACE PROTEIN-A OF BORRELIA-BURGDORFERI, Nature, 372(6506), 1994, pp. 552-555

Authors: LANGERMANN S PALASZYNSKI SR BURLEIN JE KOENIG S HANSON MS BRILES DE STOVER CK
Citation: S. Langermann et al., PROTECTIVE HUMORAL RESPONSE AGAINST PNEUMOCOCCAL INFECTION IN MICE ELICITED BY RECOMBINANT BACILLE CALMETTE-GUERIN VACCINES EXPRESSING PNEUMOCOCCAL SURFACE PROTEIN-A, The Journal of experimental medicine, 180(6), 1994, pp. 2277-2286

Authors: PASCOPELLA L COLLINS FM MARTIN JM LEE MH HATFULL GF STOVER CK BLOOM BR JACOBS WR
Citation: L. Pascopella et al., USE OF IN-VIVO COMPLEMENTATION IN MYCOBACTERIUM-TUBERCULOSIS TO IDENTIFY A GENOMIC FRAGMENT ASSOCIATED WITH VIRULENCE, Infection and immunity, 62(4), 1994, pp. 1313-1319

Authors: KOENIG S YASUTOMI Y HAUN SS STOVER CK HANSON MS GALEN JE VIGIL CL BENSON L CAIRNS JS HALLBERG PL WALSH WD JACKSON RK CONARD P CONLEY AJ EMINI EA LETVIN NL FUERST TR
Citation: S. Koenig et al., BACILLUS-CALMETTE-GUERIN (BCG) AS A LIVE VECTOR SYSTEM FOR THE INDUCTION OF IMMUNITY TO HIV AND SIV, AIDS research and human retroviruses, 9, 1993, pp. 190000028-190000028

Authors: STOVER CK BANSAL GP HANSON MS BURLEIN JE PALASZYNSKI SR YOUNG JF KOENIG S YOUNG DB SADZIENE A BARBOUR AG
Citation: Ck. Stover et al., PROTECTIVE IMMUNITY ELICITED BY RECOMBINANT BACILLE CALMETTE-GUERIN (BCG) EXPRESSING OUTER SURFACE PROTEIN-A (OSPA) LIPOPROTEIN - A CANDIDATE LYME-DISEASE VACCINE, The Journal of experimental medicine, 178(1), 1993, pp. 197-209

Authors: HICKMAN CJ STOVER CK JOSEPH SW OAKS EV
Citation: Cj. Hickman et al., MURINE T-CELL RESPONSE TO NATIVE AND RECOMBINANT PROTEIN ANTIGENS OF RICKETTSIA-TSUTSUGAMUSHI, Infection and immunity, 61(5), 1993, pp. 1674-1681
Risultati: 1-19 |